Replies to post #326296 on NorthWest Biotherapeutics Inc (NWBO)

[Sojourner55]

Its likely they registered both SNO and SITC as placeholder as part of strategy to decide when to release TLD. I've always thought the 10 minute at SNO was insufficient to elaborate on a 13 year trial and deep dive into results.

The Galbraith lecture would be the perfect forum with a one hour window on a Friday evening and no time for FUD in between if TLD is released in the morning. Not only that, the SITC poster is open on Monday and no gap in between with the weekend.

I think it is the perfect setup. Another note is Dr Keymours is also recognized for his part.

[tryn2]

BSB, wasn't it YOU who said sometimes the acquiring company will require the presenting company to withdraw...???

[HappyLibrarian]

Dr. Liau's withdrawal from SNO is bad unless we can be sure that the poster presentation for SITC does not also end up getting withdrawn in the same way with no warning or explanation.

Unfortunately, we cannot just trust the website because, as we know from the clinicaltrials.gov website, just because a website connected with NWBO has been not been updated does not mean big changes have not happened.

Just assuming that the SNO withdrawal means that the pivotal date has moved closer is the equivalent of whistling past the graveyard.

If, instead of taking the rosy view we quite reasonably consider that just like the clinical trials websites in Europe were updated but not the USA, it could be that the cancellation was shown on the SNO website for Dr. Liau but not the SITC website for the poster presentation, then this could be bad news.

I am not going to sell any shares, but once again, NWBO has at least pulled the rug out from us on SNO and I only hoping it really is so that we can get great news all the sooner at SITC.